✦ LIBER ✦

Growth pattern and expressions of cell cycle regulator proteins p53 and p21WAF1/CIP1 in early gastric carcinoma

✍ Scribed by Hiroshi Noda; Yoshihiko Maehara; Koji Irie; Yoshihiro Kakeji; Tomohiro Yonemura; Keizo Sugimachi

Publisher: John Wiley and Sons
Year: 2001
Tongue: English
Weight: 331 KB
Volume: 92
Category: Article
ISSN: 0008-543X
DOI: 10.1002/1097-0142(20011001)92:7<1828::aid-cncr1699>3.0.co;2-q

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

p21Waf1/Cip1 expression and the p53/MDM2

p21Waf1/Cip1 expression and the p53/MDM2 feedback loop in gastric carcinogenesis

✍ Craanen, M. E.; Blok, P.; Offerhaus, G. J. A.; Meijer, G. A.; Dekker, W.; Kuiper 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 109 KB

Data are non-existent regarding coincidental alterations in the expression of p53 and its downstream target genes MDM2 and p21 Waf1/Cip1 in gastric carcinogenesis. An immunohistochemical study was therefore performed to examine the interrelationships of p53, MDM2, and p21 Waf1/Cip1 expression in a s

The clinical significance of p21WAF1/CIP

The clinical significance of p21WAF1/CIP-1 and p53 expression in pancreatic adenocarcinoma

✍ Sanaa T. Dergham; Michael C. Dugan; Urwashi S. Joshi; Yong C. Chen; Wei Du; Dary 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 300 KB 👁 1 views

the pancreas were immunostained for p53 and p21. Nuclear expression was scored as absent, focal (õ10%), moderate (10 -50%), or strong or diffuse

Expression of cell-cycle regulatory prot

Expression of cell-cycle regulatory proteins cyclin D1, cyclin E, and their inhibitor p21 WAF1/CIP1 in gastric cancer

✍ M�ller, Wolfram; Noguchi, Tsuyoshi; Wirtz, Hans-Christian; Hommel, Gerhard; Gabb 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 344 KB 👁 1 views

The expression and prognostic role of cyclin D1, cyclin E, and p21 (WAF1/CIP1) were immunohistochemically investivated in 413 curatively resected gastric carcinomas. p21 was expressed in 65•4 per cent (n=270), cyclin D1 in 23•7 per cent (n=98), and cyclin E in 13•6 per cent (n=56) of the tumours. Th

p21WAF1/CIP1 expression in colorectal ca

p21WAF1/CIP1 expression in colorectal carcinoma correlates with advanced disease stage and p53 mutations

✍ Viale, Giuseppe; Pellegrini, Caterina; Mazzarol, Giovanni; Maisonneuve, Patrick; 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 221 KB 👁 2 views

Defects in the mechanisms controlling the cell cycle are crucial in cell transformation and/or tumour progression. p21 WAF1/CIP1 is an inhibitor of cyclin-dependent kinases, induced by p53-dependent and p53-independent pathways, which can block progression through the cell cycle. p21 WAF1/CIP1 expre

Prognostic value and expression of p21(w

Prognostic value and expression of p21(waf1/cip1) protein in prostate cancer

✍ Aaltomaa, S.; Lipponen, P.; Eskelinen, M.; Ala-Opas, M.; Kosma, V.M. 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 206 KB 👁 1 views

BACKGROUND. p21(waf1/cip1) protein is a cyclin-dependent kinase inhibitor able to arrest the cell cycle at the G1 phase by inhibiting DNA replication. The expression of p21(waf1/cip1) and its prognostic value in prostate cancer are largely unexplored. METHODS. We used immunohistochemistry to analyze

Multiple pathways control cell growth an

Multiple pathways control cell growth and transformation: overlapping and independent activities of p53 and p21Cip1/WAF1/Sdi1

✍ Cox, Lynne S. 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 91 KB

Many tumour therapies act by inducing a cellular damage response pathway mediated by the tumour suppressor protein p53. Alternative outcomes of p53 induction include apoptosis or transient cell-cycle arrest, both thought to require the transcriptional activity of wild-type p53. Current research high